Hay DW - Search Results

1

Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist.

Sarau HM, Griswold DE, Potts W, Foley JJ, Schmidt DB, Webb EF, Martin LD, Brawner ME, Elshourbagy NA, Medhurst AD, Giardina GA, Hay DW. Sarau HM, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1997 Jun;281(3):1303-11. J Pharmacol Exp Ther. 1997. PMID: 9190866

2

Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.

Hay DW, Giardina GA, Griswold DE, Underwood DC, Kotzer CJ, Bush B, Potts W, Sandhu P, Lundberg D, Foley JJ, Schmidt DB, Martin LD, Kilian D, Legos JJ, Barone FC, Luttmann MA, Grugni M, Raveglia LF, Sarau HM. Hay DW, et al. J Pharmacol Exp Ther. 2002 Jan;300(1):314-23. doi: 10.1124/jpet.300.1.314. J Pharmacol Exp Ther. 2002. PMID: 11752131

3

Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.

Salmon M, Luttmann MA, Foley JJ, Buckley PT, Schmidt DB, Burman M, Webb EF, DeHaas CJ, Kotzer CJ, Barrett VJ, Slack RJ, Sarau HM, Palovich MR, Lainé DI, Hay DW, Rumsey WL. Salmon M, et al. Among authors: hay dw. J Pharmacol Exp Ther. 2013 May;345(2):260-70. doi: 10.1124/jpet.112.202051. Epub 2013 Feb 22. J Pharmacol Exp Ther. 2013. PMID: 23435542

4

Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.

Chabot-Fletcher MC, Underwood DC, Breton JJ, Adams JL, Kagey-Sobotka A, Griswold DE, Marshall LA, Sarau HM, Winkler JD, Hay DW. Chabot-Fletcher MC, et al. Among authors: hay dw. J Pharmacol Exp Ther. 1995 Jun;273(3):1147-55. J Pharmacol Exp Ther. 1995. PMID: 7791085

5

2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor.

Giardina GA, Sarau HM, Farina C, Medhurst AD, Grugni M, Foley JJ, Raveglia LF, Schmidt DB, Rigolio R, Vassallo M, Vecchietti V, Hay DW. Giardina GA, et al. Among authors: hay dw. J Med Chem. 1996 Jun 7;39(12):2281-4. doi: 10.1021/jm9602423. J Med Chem. 1996. PMID: 8691422 No abstract available.

6

Characterization of NK3 receptors in rabbit isolated iris sphincter muscle.

Medhurst AD, Parsons AA, Roberts JC, Hay DW. Medhurst AD, et al. Among authors: hay dw. Br J Pharmacol. 1997 Jan;120(1):93-101. doi: 10.1038/sj.bjp.0700867. Br J Pharmacol. 1997. PMID: 9117105 Free PMC article.

7

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 1. Identification of the 4-quinolinecarboxamide framework.

Giardina GA, Sarau HM, Farina C, Medhurst AD, Grugni M, Raveglia LF, Schmidt DB, Rigolio R, Luttmann M, Vecchietti V, Hay DW. Giardina GA, et al. Among authors: hay dw. J Med Chem. 1997 Jun 6;40(12):1794-807. doi: 10.1021/jm960818o. J Med Chem. 1997. PMID: 9191956

8

In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.

Medhurst AD, Hay DW, Parsons AA, Martin LD, Griswold DE. Medhurst AD, et al. Among authors: hay dw. Br J Pharmacol. 1997 Oct;122(3):469-76. doi: 10.1038/sj.bjp.0701406. Br J Pharmacol. 1997. PMID: 9351503 Free PMC article.

9

Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412).

Giardina GA, Raveglia LF, Grugni M, Sarau HM, Farina C, Medhurst AD, Graziani D, Schmidt DB, Rigolio R, Luttmann M, Cavagnera S, Foley JJ, Vecchietti V, Hay DW. Giardina GA, et al. Among authors: hay dw. J Med Chem. 1999 Mar 25;42(6):1053-65. doi: 10.1021/jm980633c. J Med Chem. 1999. PMID: 10090788

10

Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists.

Giardina GA, Artico M, Cavagnera S, Cerri A, Consolandi E, Gagliardi S, Graziani D, Grugni M, Hay DW, Luttmann MA, Mena R, Raveglia LF, Rigolio R, Sarau HM, Schmidt DB, Zanoni G, Farina C. Giardina GA, et al. Among authors: hay dw. Farmaco. 1999 Jun 30;54(6):364-74. doi: 10.1016/s0014-827x(99)00043-9. Farmaco. 1999. PMID: 10443017

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page